Tsang et al. highlighted the markedly altered super-enhancer landscape in HCC, showing gains of super-enhancers at the promoters of key oncogenes such as SPHK1, MYC, MYCN, SHH, and YAP1, resulting in their transcriptional upregulation [93]. Here, MYC is linked to hepatocellular carcinoma.